Analyzing the synthesis route of 494-52-0

I hope my short article helps more people learn about this compound((S)-3-(Piperidin-2-yl)pyridine)Reference of (S)-3-(Piperidin-2-yl)pyridine. Apart from the compound(494-52-0), you can read my other articles to know other related compounds.

Reference of (S)-3-(Piperidin-2-yl)pyridine. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: (S)-3-(Piperidin-2-yl)pyridine, is researched, Molecular C10H14N2, CAS is 494-52-0, about Long-term trends in tobacco use assessed by wastewater-based epidemiology and its relationship with consumption of nicotine containing products. Author is Zheng, Qiuda; Gartner, Coral; Tscharke, Benjamin J.; O’Brien, Jake W.; Gao, Jianfa; Ahmed, Fahad; Thomas, Kevin V.; Mueller, Jochen F.; Thai, Phong K..

Measurement of population tobacco use via wastewater-based epidemiol. (WBE) provides objective data to evaluate the efficacy of tobacco control strategies. However, current WBE tobacco-use estimates based on nicotine metabolites (cotinine and hydroxycotinine) can be masked by use of non-tobacco nicotine-containing products. To better understand nicotine and tobacco use, we analyzed tobacco-specific biomarkers, anabasine and anatabine, as well as nicotine metabolites, cotinine and hydroxycotinine, in wastewater samples collected for 6 wk per yr over 6 years (2012-2017) from an Australian wastewater treatment plant serving approx. 100,000 people. Significant annual declines were observed for anabasine, anatabine, cotinine and hydroxycotinine of -3.0%, -2.7%, -2.4%, and -2.1%, resp. The results corresponded with the annual declining trends reported from surveys (-5%) and taxation statistics (-4%). Significant annual decreases in the ratios of anabasine to cotinine (-1.2%) and anatabine to cotinine (-1.0%) suggested a relative increase in the use of non-tobacco nicotine products at the same time that tobacco use was declining. Monitoring tobacco use with anabasine and anatabine removed influence from nicotine-containing products, showing larger reductions in this Australian city than via nicotine biomarkers, while also demonstrating their suitability for monitoring long-term trends.

I hope my short article helps more people learn about this compound((S)-3-(Piperidin-2-yl)pyridine)Reference of (S)-3-(Piperidin-2-yl)pyridine. Apart from the compound(494-52-0), you can read my other articles to know other related compounds.

Reference:
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI